Combination of ZD6474, an inhibitor of the vasuclar endothelial growth factor receptor, with radiotherapy in the treatment of cancer

Details for Australian Patent Application No. 2003249000 (hide)

Owner AstraZeneca AB

Inventors WEDGE, Stephen, Robert

Agent Davies Collison Cave

Pub. Number AU-B-2003249000

PCT Number PCT/GB03/03388

PCT Pub. Number WO2004/014383

Priority 0218525.4 09.08.02 GB; 0307560.3 02.04.03 GB

Filing date 5 August 2003

Wipo publication date 25 February 2004

Acceptance publication date 5 April 2007

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 0218525.4 09.08.02 GB; 0307560.3 02.04.03 GB

8 April 2004 Application Open to Public Inspection

  Published as AU-B-2003249000

5 April 2007 Application Accepted

  Published as AU-B-2003249000

2 August 2007 Standard Patent Sealed

3 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003249001-AUXETIC TUBULAR LINERS

2003248999-A CASE